Cannatonic 13% CBD, 7% THC
A new study published in the journal Fundamental & Clinical Pharmacology has found that cannabidiol, a compound found in cannabis, may treat OCD.
According to the start of the study’s abstract; “Cannabidiol (CBD), one of the main components of Cannabis sp, presents clinical and preclinical anxiolytic properties. Recent results using the marble-burying test (MBT) suggest that CBD can also induce anticompulsive-like effects.”
“This study represents the first direct demonstration of the role of the endocannabinoid system on the antihyperalgesic effect of ankle joint mobilization.”
Researchers at the University of Sao Paulo’s School of Medicine tested cannabidiol on rats with OCD, and found that; “The results, in addition to reinforcing a possible anti-compulsive effect of CBD, also suggest that mCPP-induced repetitive burying could be a useful test for the screening of compounds with presumed anticompulsive properties.”
Researchers conclude that; “the serotonergic and cannabinoid systems interact to control repetitive behaviors, although the precise nature of this interaction is not clear.”
This study was also published online by the National Institute of Health.
Sour Tsunami strain 10-11% CBD and 6-7% THC
The study can be found here:
Cannabidiol (CBD) Rich Cannabis strains
Cannatonic 13% CBD, 7% THC
Sour Tsunami 10-11% CBD , 6-7% THC
Omrita Rx3 9-12% CBD, 5-7% THC
True Blueberry/OG Kush 9.4% CBD, 4.8% THC
Jamaican Lion 8.91% CBD, 5.54% THC
Harlequin 4% CBD, 2% THC / 75% sativa and 25 % indica
Juanita la Lagrimosa 8.8% CBD, 6.8% THC
Good Medicine 9.03% CBD, 8.2%THC
Misty 7% CBD, 10% THC
Soma A+
Stinky Purple
Cotton Candy/Diesel
Rx Red
Poison OG
Juanita La Lagrimosa strain 8.8% CBD, 6.8% THC
No comments:
Post a Comment